TP53 and Miyoshi myopathy: To further investigate the association between loss of plasma cell identity, genomic complexity and suboptimal response to anti-BCMA redirecting therapies, we leveraged recently developed Bclγ1, MIcγ1, and TP53–Bclγ1 mouse models of MM.